Mechanism of Action and Pharmacological Effects
Chemically, the drug is an iminostilbene derivative. The broad spectrum of carbamazepine's pharmacological activity is due to its ability to affect neuronal membranes.
The primary target of the drug is voltage-gated sodium channels of nerve cells. The mechanism of action is realized at two levels:
- At the neuronal soma: Carbamazepine blocks sodium channels, which sharply reduces the ability of nerve cells to sustain high-frequency firing. Such pathological high-frequency activity is typical of an epileptogenic focus in the brain.
- Presynaptic action: It is hypothesized that the drug also blocks presynaptic sodium channels. This prevents the excessive release of excitatory neurotransmitters into the synaptic cleft.
As a result, the drug exerts not only a classic antiepileptic effect, but also demonstrates analgesic activity (pain relief), an antidepressant effect, and acts as a mood stabilizer by smoothing out emotional fluctuations.
Main Indications for Use
Due to its complex effects on the central nervous system, carbamazepine is used in several medical fields:
- In epileptology: It is considered a first-line drug for the prophylaxis of generalized tonic-clonic seizures and focal (partial) seizures.
- In neurology: It is the gold standard and drug of choice in the treatment of trigeminal neuralgia. In this case, its ability to alleviate intense neuropathic pain plays a pivotal role.
- In psychiatry: It is actively used for the prophylaxis of manic-depressive states (bipolar disorders) due to its mood-stabilizing and antidepressant profile.
Pharmacokinetics
The pharmacokinetic profile of carbamazepine has several critical features that must be considered when titrating the dose.
- Absorption and distribution: The drug is almost completely absorbed from the gastrointestinal tract, although absorption rates vary widely among patients. Peak plasma concentrations are reached in an average of 4–5 hours. Notably, carbamazepine readily passes into breast milk, reaching concentrations up to 60% of maternal plasma levels.
- Metabolism and autoinduction: Biotransformation occurs in the liver. A key feature of the drug is the autoinduction phenomenon. Carbamazepine induces hepatic microsomal enzymes, thereby accelerating its own metabolism. Biotransformation yields an active metabolite, carbamazepine-10,11-epoxide, which also possesses anticonvulsant, anti-neuralgic, and antidepressant activity.
- Elimination: The drug is eliminated from the body predominantly via the kidneys (over 70% of the dose is excreted).
Side Effects and Complications
Administration of carbamazepine can be accompanied by adverse reactions across various body systems, necessitating careful clinical monitoring.
- CNS and special senses: Patients frequently report drowsiness, headaches, and ataxia. Visual disturbances such as accommodation disorders and diplopia (double vision) may occur.
- Hematopoietic system: This is a zone of special risk. The drug can cause leukopenia, thrombocytopenia, and even life-threatening agranulocytosis. For this reason, regular complete blood count monitoring is critical.
- Cardiovascular system and GI tract: Cardiac rhythm disturbances may develop. Gastrointestinal side effects include loss of appetite, nausea, and, in rare cases, hepatitis.
- Metabolism and hypersensitivity: Therapy can disrupt electrolyte balance, leading to hyponatremia and hypocalcemia. Allergic reactions of varying severity are also possible.
Special Warnings and Drug Interactions
Prescribing carbamazepine requires careful consideration of its interactions with the body and other medications.
Use in pregnancy: The drug has a documented teratogenic effect. Its use in pregnant women is justified exclusively by strict life-threatening indications, when the risk of uncontrolled seizures outweighs the risk to the fetus.
Effect on psychomotor function: Carbamazepine significantly slows reaction times. Activities requiring high concentration and rapid reflexes, including driving motor vehicles, are strictly contraindicated for patients.
Drug interactions: Due to pronounced hepatic enzyme induction, carbamazepine significantly lowers the blood concentration of many other drugs when co-administered. This is especially important in combination antiepileptic therapy, as it accelerates the elimination of clonazepam, lamotrigine, and ethosuximide.